Albert Labs International (XCNQ:ABRT) Dividend Payout Ratio : 0.00 (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Dividend Payout Ratio?

Albert Labs International's dividend payout ratio for the months ended in Sep. 2023 was 0.00.

The historical rank and industry rank for Albert Labs International's Dividend Payout Ratio or its related term are showing as below:

XCNQ:ABRT's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-25), the Dividend Yield % of Albert Labs International is 0.00%.

Albert Labs International's Dividends per Share for the months ended in Sep. 2023 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Albert Labs International Dividend Payout Ratio Historical Data

The historical data trend for Albert Labs International's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Dividend Payout Ratio Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

Dividend Payout Ratio

Albert Labs International Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Dividend Payout Ratio	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Albert Labs International's Dividend Payout Ratio

For the Biotechnology subindustry, Albert Labs International's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Albert Labs International's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Albert Labs International's Dividend Payout Ratio falls into.

Albert Labs International Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Albert Labs International's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2022 )	/	EPS without NRI (A: Dec. 2022 )
	=	0	/	-0.078
	=	N/A

Albert Labs International's Dividend Payout Ratio for the quarter that ended in Sep. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2023 )	/	EPS without NRI (Q: Sep. 2023 )
	=	0	/	-0
	=	N/A

Albert Labs International (XCNQ:ABRT) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Albert Labs International Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines